ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,876Medicare Part D Prescriptions Filled, Including Refills

Rank: 137 out of 2343

$1.09M Total Retail Price of All Prescriptions

Rank: 89 out of 2343

502 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 502 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 502 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 15,628 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 925 853 1 2
LISINOPRIL 616 572 2 3
SIMVASTATIN 460 436 3 1
OMEPRAZOLE 394 363 4 4
JANTOVEN 384 367 5 81
CITALOPRAM HBR 376 336 6 17
AMLODIPINE BESYLATE 341 329 7 5
ATORVASTATIN CALCIUM 338 314 8 10
WARFARIN SODIUM 300 292 9 8
FUROSEMIDE 300 295 9 6
METOPROLOL SUCCINATE 297 290 11 14
METFORMIN HCL 293 274 12 9
CRESTOR 288 251 13 30
METOPROLOL TARTRATE 288 281 13 7
DIOVAN 286 257 15 23
CARVEDILOL 251 246 16 27
IPRATROPIUM-ALBUTEROL 251 251 16 99
NAMENDA 249 249 18 36
SERTRALINE HCL 226 209 19 20
DONEPEZIL HCL 224 224 20 21
ALLOPURINOL 214 191 21 31
NEXIUM 203 180 22 33
HYDROCHLOROTHIAZIDE 182 169 23 11
RANITIDINE HCL 155 120 24 43
MIRTAZAPINE 147 147 25 41
CLOPIDOGREL 144 142 26 26
SPIRIVA 144 139 26 48
KLOR-CON M20 141 136 28 44
TRAMADOL HCL 140 132 29 25
HYDROCODONE-ACETAMINOPHEN 139 126 S3 30 13
GABAPENTIN 137 132 31 16
TAMSULOSIN HCL 132 129 32 29
ATENOLOL 131 119 33 12
TRAZODONE HCL 130 118 34 53
RAMIPRIL 129 125 35 90
POTASSIUM CHLORIDE 128 110 36 18
EXELON 125 125 37 129
DIGOXIN 121 121 38 35
GLIMEPIRIDE 117 104 39 45
ADVAIR DISKUS 111 102 40 34
SYMBICORT 108 84 41 167
NOVOLOG 106 105 42 110
ISOSORBIDE MONONITRATE ER 105 105 43 32
PANTOPRAZOLE SODIUM 104 82 44 22
PLAVIX 104 100 44 38
AVODART 98 98 46 165
ALENDRONATE SODIUM 98 82 46 28
DIOVAN HCT 96 96 48 63
PRAVASTATIN SODIUM 91 90 49 15
ESCITALOPRAM OXALATE 91 88 49 55
JANUVIA 89 87 51 50
FENTANYL 86 85 S2 52 69
RISPERIDONE 86 86 52 61
BUMETANIDE 73 54 54 91
TRICOR 73 62 54 96
CIPROFLOXACIN HCL 71 67 56 72
VESICARE 70 66 57 145
VENLAFAXINE HCL ER 70 70 57 87
BYSTOLIC 68 63 59 123
OXYBUTYNIN CHLORIDE 68 56 59 169
AZITHROMYCIN 65 58 61 39
SYNTHROID 65 65 61 40
DOXAZOSIN MESYLATE 63 63 63 98
LANTUS 60 60 64 51
OXYCODONE-ACETAMINOPHEN 60 59 S2 64 49
MEGESTROL ACETATE 55 55 R 66 246
NOVOLIN N 55 55 66 300
TRILIPIX 53 40 68 214
PREDNISONE 53 46 68 37
LEVEMIR 52 52 70 250
FINASTERIDE 52 52 70 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 13, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.